RAFFA WEALTH MANAGEMENT, LLC

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 1631073 WASHINGTON, DC

Position in TEVA

as of Jun 30, 2026 · filed Jul 27, 2026 Compact

Position Value

$1,287

+$143 QoQ

Shares Held

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#644

of 671 holders

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

RAFFA WEALTH MANAGEMENT, LLC holds $34,977 across 13 Drug Manufacturers - Specialty & Generic names. TEVA ranks #8 (3.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RDY	Dr Reddys Laboratories Ltd	683	$9,896
2	ZTS	Zoetis Inc.	105	$7,545
3	NBIX	Neurocrine Biosciences Inc	24	$4,044
4	HLN	Haleon plc	368	$3,433
5	TAK	Takeda Pharmaceutical Co Ltd	208	$3,334
6	VTRS	Viatris Inc	143	$2,270
7	ELAN	Elanco Animal Health Inc	73	$1,796
8	TEVA	Teva Pharmaceutical Industries Ltd This page	38	$1,287

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,287	38	0.0%	Shares	Sole	2026-07-27
2026-03-31	$1,144	38	0.0%	Shares	Sole	2026-07-27
2025-12-31	$1,185	38	-33.3%	Shares	Sole	2026-07-27
2025-09-30	$1,151	57	0.0%	Shares	Sole	2026-07-27
2025-06-30	$955	57	0.0%	Shares	Sole	2026-07-27
2025-03-31	$876	57	0.0%	Shares	Sole	2026-07-27
2024-12-31	$1,256	57	0.0%	Shares	Sole	2026-07-27
2024-09-30	$1,027	57	0.0%	Shares	Sole	2026-07-27
2024-06-30	$926	57	-36.7%	Shares	Sole	2026-07-27
2020-12-31	$868	90	0.0%	Shares	Sole	2026-07-27
2020-09-30	$810	90	0.0%	Shares	Sole	2026-07-27
2020-06-30	$1,109	90	0.0%	Shares	Sole	2026-07-27
2020-03-31	$808	90	—	Shares	Sole	2026-07-27
No filing history on record for this holder in this stock.